Icrest Biotechnologies Limited - Company Profile

It is a healthcare public limited company based in Bangalore, Karnataka, India, established in 2008.
2008 Bangalore, Karnataka, India Active
Last Updated:
About Icrest Biotechnologies Limited

Icrest Biotechnologies Limited, a active public limited company, was established on 17 September 2008 in Bangalore, Karnataka, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U33100KA2008PLC047800. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.17 Cr.

It upholds a compliant status. Its leadership includes Gururaj Ananda Rao (Managing Director), Gopalakrishna Sreemushanam Anandarao (Director), Jyothsna Ananda Rao (Whole-Time Director). Past directors included Gururaj Ananda Rao, Gopalakrishna Sreemushanam Anandarao, Jyothsna Ananda Rao. It holds ₹6.85 M open charges and ₹2.77 M settled loans. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at No.117, Venkateshapura Jakkur Post, Yelahanka Hobli, Bangalore, Karnataka, 560064.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33100KA2008PLC047800

  • Registration Number

    047800

  • Incorporation Date

    17 September 2008

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹1.17 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.17 Cr
  • Company Age 17 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 6.85 M
  • Satisfied Charges ₹ 2.77 M
  • Revenue Growth **** 14.71%
  • Profit Growth **** 44.29%
  • Ebitda **** -158.97%
  • Net Worth 159.09%
  • Total Assets **** 12.31%
Company report

Icrest Biotechnologies Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Icrest Biotechnologies Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Icrest Biotechnologies Limited?
Current Directors
Name Designation Appointment Date Status
Gururaj Ananda Rao Managing Director 01 Dec 2010 Current
Gopalakrishna Sreemushanam Anandarao Director 17 Sep 2008 Current
Jyothsna Ananda Rao Whole-Time Director 17 Sep 2008 Current
Basavalinga Ajaikumar Sadasivaiah Director 28 Feb 2024 Current
Sunanda Ananda Rao Director 01 Mar 2010 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 08 Mar 2010 Past
Pramod Abcsdd Whole-Time Director 05 Sep 2022 Past
Pramod Abcsdd Director 05 Sep 2022 Past
Pramod Abcsdd Director 06 Mar 2010 Past
Pramod Abcsdd Additional Director 17 Sep 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Icrest Biotechnologies.

International Stemcell Services Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.71% increase. The company also saw a substantial improvement in profitability, with a 44.29% increase in profit. The company's net worth Soared by an impressive increase of 159.09%.

Icrest Biotechnologies revenue growth over time
Icrest Biotechnologies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
14.71%
*******
*******
*******
*******
Revenue from Operations
*******
-12.15%
*******
*******
*******
*******
Total Assets
*******
12.31%
*******
*******
*******
*******
Profit or Loss
*******
44.29%
*******
*******
*******
*******
Net Worth
*******
159.09%
*******
*******
*******
*******
EBITDA
*******
-158.97%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Icrest Biotechnologies?

In 2022, Icrest Biotechnologies had a promoter holding of 60.85% and a public holding of 39.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹6,853,000.00

Satisfied Charges

₹2,765,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 0.69 Cr
Latest Charge Details
Date Lender Amount Status
24 Oct 2024 Hdfc Bank Limited ₹6.85 M Open
05 Dec 2015 Icici Bank Limited ₹0.37 M Satisfied
31 Dec 2013 Corporation Bank ₹2.40 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Icrest Biotechnologies?

Unlock and access historical data on people associated with Icrest Biotechnologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Icrest Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Icrest Biotechnologies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Icrest Biotechnologies
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Icrest Biotechnologies Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Icrest Biotechnologies Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.69 Cr with Charge ID 101016493 was registered on 24 Oct 2024. was documented.

  • Director Appointment

    Progress on Basavalinga Ajaikumar Sadasivaiah was appointed as a Director was appointed as a Director on 28 Feb 2024 & has been associated with this company since 1 year 11 months . was documented.

  • Charges

    Progress on A charge registered on 05 Dec 2015 via Charge ID 10619056 with Icici Bank Limited was fully satisfied on 28 Jan 2019. was documented.

  • Charges

    Progress on A charge registered on 31 Dec 2013 via Charge ID 10473800 with Corporation Bank was fully satisfied on 09 Dec 2015. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Icrest Biotechnologies Limited?

The CIN of Icrest Biotechnologies Limited is U33100KA2008PLC047800.

Where is Icrest Biotechnologies Limited headquartered?

Icrest Biotechnologies Limited is headquartered at No.117, Venkateshapura Jakkur Post, Yelahanka Hobli, Bangalore, Karnataka, 560064.

When was Icrest Biotechnologies Limited incorporated?

Icrest Biotechnologies Limited was incorporated on 17 September 2008.

Who are the current directors of Icrest Biotechnologies Limited?
What is the primary industry of Icrest Biotechnologies Limited?

The primary industry of Icrest Biotechnologies Limited is Hospital And Medical Care.

Is Icrest Biotechnologies Limited a listed company?

Icrest Biotechnologies Limited is unlisted.

What is the capital structure of Icrest Biotechnologies Limited?

The authorized capital of Icrest Biotechnologies Limited is ₹2.00 Cr, and the paid-up capital is ₹1.17 Cr.

What is the compliance status of Icrest Biotechnologies Limited?

The compliance status of Icrest Biotechnologies Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available